EUVIMEDScopri EUVIMED
Open access

AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy

Benedette Cuffari

Journal of Medical Internet Research · 2026-07-09 · 28 · e106201-e106201

DOI: 10.2196/106201 ↗

At a glance

Journal article in Journal of Medical Internet Research, published online on 2026-07-09. Written by Benedette Cuffari. Major MEDLINE topics: Radiopharmaceuticals, Precision Medicine, Neoplasms, Machine Learning. The full text is freely available in PubMed Central.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Computing advances are helping improve the precision and effectiveness of cancer treatment. In this News and Perspectives article, JMIR Correspondent Benedette Cuffari reports on recent AI applications for radiopharmaceutical therapy, as well as the current state of the field and its future potential.

Subjects

MeSH terms (MEDLINE)

RadiopharmaceuticalsPrecision MedicineNeoplasmsMachine LearningArtificial IntelligenceHumans

Author keywords

personalized medicinedeep learningradioligand discoveryradiopharmaceuticalstheranostics

Substances

Radiopharmaceuticals

Cite

APA

Cuffari, B. (2026). AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy. Journal of Medical Internet Research, 28, e106201-e106201. https://doi.org/10.2196/106201

Vancouver

Cuffari B. AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy. Journal of Medical Internet Research. 2026;28:e106201-e106201. doi:10.2196/106201

BibTeX
@article{Cuffari2026,
  author = {Cuffari, Benedette},
  title = {AI-Designed Radiopharmaceuticals: How Machine Learning Is Redefining Precision Cancer Therapy},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e106201--e106201},
  doi = {10.2196/106201}
}
Start for free →